Twitter Beğeni Hilesi

After 20+ years in Primary Care, I'm doing something a little different. nymag.com/intelligencer/…

Amazing talk delivered by Lisa McCorkell Patient-Led Research Collaborative on the importance of patient input and involvement in #longcovid research and learning from other post acute infection syndromes 👏🏼👏🏼👏🏼 #KSLongCoVID24

I am grateful for likeminded researchers like our rockstar scientist Prof. Akiko Iwasaki and Michael Peluso, MD, Jeroen den Dunnen, Rob Wüst team (many more) who attended the Keystone Symposia are working tirelessly on LC! Also PolyBio Putrino Lab Michael VanElzakker Prof Doug Kell CBE #FBPE #FBPA🔶🇪🇺 Dr Asad Khan FRCP FRACP 🇵🇸🇳🇿🇮🇳🇬🇧#pwLC

Which people living with HIV should be on statins after REPRIEVE? And which statin?? Watch some world experts break it down during last week's HIV Grand Rounds: youtube.com/watch?v=L4pnRH… 👏 Dr. Peter Hunt, Dr. Priscilla Hsue, Dr. Colette Dejong

#ECGChallenge: Chest pain, bundle branch block, and wide complex tachycardia: Is three a company or a crowd? Matt Durstenfeld, MD MAS #AHAJournals ahajournals.org/doi/10.1161/CI…

👋An official welcome to Saate Shakil! We are so happy to have you at Zuckerberg SF General Hospital & Trauma Center. Dr. Shakil will help lead the global cardiology program at ZSFG. #ZSFGCards #WomeninCardiology Priscilla Hsue

Recent study reports high prevalence of chronotropic incompetence in those with HIV, raising crucial questions about its root causes and links to antiretroviral therapy and inflammation. #AHAJournals Matt Durstenfeld, MD MAS UCSF Cardiology UCSF HIVIDGM ahajrnls.org/3FuJ5j8

Join us at the UC San Francisco 40th Annual Advances in Heart Disease Course, Dec 8-10, 2023. Virtual & in-person at Mission Bay Conf Center, SF. Explore the latest in heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention, and AI. cme-reg.configio.com/pd/2943

.NIH_NHLBI: Tom Pearson and colleagues publish the #NHLBI-supported state-of-the art review on the science of #Precision #Prevention: Research opportunities and clinical applications to⬇️cardiovascular health #disparities. #ImpSci @NIH @NHLBI_HeartDir jacc.org/doi/10.1016/j.…

Drs. Lucas Zier Zuckerberg SF General Hospital & Trauma Center and Jonathan Davis, MD, MPHS lead heart failure efforts recognized by America's Essential Hospitals. Their work incorporates #SocialDeterminantsOfHealth, resulting in >10% drop in 30-day readmissions, reduced mortality & decreased racial disparities.

Paxlovid during 1st acute COVID doesn't prevent #LongCOVID among vaccinated people in the Covid Citizen Science Study; rebound also not associated with #LongCovid @ucsf UC San FranciscoCardiology UCSF HIVIDGM Michael Peluso, MD Read our full paper here: onlinelibrary.wiley.com/doi/10.1002/jm…

Hoping to speed up understanding of long COVID, UCSF researchers announced the opening of the world’s first bank of tissue specimens from people who have the mysterious disorder. trib.al/43NToG6

Today, the #Stanford #Paxlovid trial for #LongCOVID (STOP-PASC) reported no difference in patient reported outcomes between drug vs placebo. Headlines say it's "negative," some are saying we should abandon the virus persistence hypothesis. My take: jamanetwork.com/journals/jamai…

New🫀pub: Should we 👀 for cororary artery disease in #HF? Association Between Coronary Assessment in Heart Failure and Clinical Outcomes Within a Safety-Net Setting Using a Target Trial Emulation Observational Design | Circulation: CQO ahajournals.org/doi/10.1161/CI…

New paper out with Kristine Erlandson: Chronotropic Incompetence Among People With #HIV Improves With Exercise Training in the Exercise for Healthy Aging Study academic.oup.com/jid/article-ab… UCSF Cardiology UCSF HIVIDGM

New UC San Francisco #LIINC paper: immune activation & viral persistence in tissue up to 2 years post-COVID. Found double-stranded RNA in #LongCOVID, suggesting active reservoir persists and evades immune clearance. Thanks PolyBio, NIH for support. Science Translational Medicine science.org/doi/10.1126/sc…

Long overdue statement from the White House on #longCOVID. whitehouse.gov/briefing-room/…

A single combined measure of hsCRP, LDL-C, and Lp(a) among initially healthy women was predictive of incident cardiovascular events over a 30-year period. All 3 biomarkers are modifiable thru either lifestyle or pharmacologic interventions #ESCCongress #cardiology #prevention

Has the time come for universal screening of 3 simple modifiable risk markers: hsCRP, LDL, and Lp(a)? A study in 27,939 initially healthy women show these 3 modifiable markers are predictive of long-term CV outcomes over 30 years. Watch Dr. Ridker discuss findings here

This paper on thromboinflammation is everywhere this week. Unfortunately nobody commenting on it seems to have read it! I have, and it definitely doesn't say what commentators are suggesting. 🧵nature.com/articles/s4158…